Vivodyne
A senior bioengineering scientist supporting the development and operation of advanced human tissue models for therapeutic discovery and translational research. This role involves working closely with scientists, engineers, and software teams to support large-scale tissue culture workflows, execute assays, and maintain automated systems.
Vivodyne is a frontier bio-AI lab that generates human data at AI scale using autonomous robotic laboratories (HIVEs) and the most realistic lab-grown human tissues ever grown outside the body. Their platform combines advanced microfluidic TissueDisk chips, self-assembling organ tissues, and multi-modal single-cell data generation to produce large-scale perturbational datasets for training human tissue foundation models. Vivodyne partners with leading biopharma companies to advance therapeutics development with human data before the clinic.
Bioengineering Spin-off Vivodyne on Fast Company’s ‘Most Innovative’ List
Nov 12, 2025
Vivodyne raises $40M to replace animal testing with AI and robotics
May 29, 2025
As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs
May 29, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vivodyne.
16% below the average for this role
Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate
May 29, 2025
Research Assistant
National University of Singapore
Senior Research Associate, In Vivo Discovery
Pivotal
Contract Research Associate
Pliant Therapeutics, Inc.
Intern – Cell Biology (6 Month Contract)
Monte Rosa Therapeutics, Inc
Senior Research Associate, Platform Biology
Deep Genomics
Scientist, Virology and Vaccines Discovery
AstraZeneca